Skip to main content

The National Comprehensive Cancer Network Oncology Research Program, in collaboration with Pfizer Independent Grants for Learning & Change, has awarded 10 grants for project proposals to improve patient care and outcomes in metastatic breast cancer. A proposal from UNC Lineberger researcher Stephanie Wheeler was among the winning projects.

image2

A project proposal by a UNC Lineberger Comprehensive Cancer Center researcher was one of 10 projects selected to receive grant funding from the National Comprehensive Cancer Network Oncology Research Program and Pfizer Independent Grants for Learning & Change.

Stephanie Wheeler, PhD, MPH, a UNC Lineberger member and an assistant professor in the UNC Gillings School of Global Public Health, was awarded $295,485 for a project proposalImplementing and Evaluating Medication Assistance Programming in Metastatic Breast Cancer.”

Wheeler’s project was one of 10 selected from a a call for proposals to develop and adopt evidence-based initiatives to improve patient care and outcomes in metastatic breast cancer. In 2015, NCCN ORP and Pfizer IGLC issued a Request for Proposals (RFP) to any organization with an interest in improving patient care including academic and community hospitals.

“Breast cancer is a leading cause of cancer death in women in the United States, and these projects indeed couple education with performance in order to heighten awareness and utilization of evidence-based treatment guidelines for the disease,” said Robert C. Young, MD, interim vice president of NCCN ORP, in a prepared statement.

The other funded proposals were: